1. Central Nervous System Drugs Market Executive Summary 2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Type
6.3. Segmentation By Distribution Channel
6.4. Segmentation By Route Of Administration
6.5. Segmentation By Drug Classification
6.6. Segmentation By Mode Of Purchase
7. Central Nervous System Drugs Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Type
7.2.1. Multiple Sclerosis (MS)
7.2.2. Anti-Psychotic
7.2.3. Analgesics
7.2.4. Anti-Parkinson Drugs
7.2.5. Anesthetics
7.2.6. Anti-Epileptics
7.2.7. Anti-Depressants
7.2.8. Other CNS Drugs
7.3. Market Segmentation By Distribution Channel
7.3.1. Hospitals Pharmacies
7.3.2. Retail Pharmacies/ Drug Stores
7.3.3. Others
7.4. Market Segmentation By Route Of Administration
7.4.1. Oral
7.4.2. Intravenous
7.4.3. Intranasal/ Inhalation
7.4.4. Others
7.5. Market Segmentation By Drug Classification
7.5.1. Branded Drugs
7.5.2. Generic Drugs
7.6. Market Segmentation By Mode Of Purchase
7.6.1. Over-The-Counter Drugs
7.6.2. Prescription-Based Drugs
8. Central Nervous System Drugs Market, Supply Chain Analysis
8.1. Supply Chain
8.1.1. Raw Material Suppliers
8.1.2. Contract Research Organization (CRO)
8.1.3. Central Nervous System Drugs Manufacturer
8.1.4. Contract Manufacturing Organization (CMO)
8.2. Distribution
8.2.1. Wholesalers/Distributors
8.2.2. Retailers (Pharmacies) And Hospitals
8.2.3. Neurologists
8.3. End-Users
9. Central Nervous System Drugs Market, Product Analysis – Product Examples
10. Central Nervous System Drugs Market Customer Information
10.1. Usage of Central Nervous System Medicines In Old Age Homes
10.2. Study On Effectiveness Of Anti-Depressants
10.3. Lower Approval Rates For Central Nervous System Drugs
11. Central Nervous System Drugs Market Trends And Strategies
11.1. Wearables To Improve R&D
11.2. Biomarkers In CNS Drug Development
11.3. Modification Of Existing Epilepsy Drugs
11.4. Collaborations For CNS Drug Development
11.5. Drug Pipeline
11.6. 3D Printing Technology
12. Leading Central Nervous System Drugs
13. Pipeline Drugs
14. Impact Of COVID-19 On The Central Nervous System Drugs Market
14.1. Clinical Trial Delays
14.2. Supply Chain Issues
14.3. Increasing Demand For Anti-Depressants Due To COVID-19
14.4. Future Outlook
15. Global Central Nervous System Drugs Market Size And Growth
15.1. Market Size
15.2. Historic Market Growth, 2015 – 2020, Value ($ Million)
15.2.1. Drivers Of The Market 2015 – 2020
15.2.2. Restraints On The Market 2015 – 2020
15.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
15.3.1. Drivers Of The Market 2020 – 2025
15.3.2. Restraints On The Market 2020 – 2025
16. Central Nervous System Drugs Market, Regional Analysis
16.1. Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16.2. Global Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Region
16.3. Global Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region
17. Global Central Nervous System Drugs Market Segmentation
17.1. Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.1.1. Multiple Sclerosis
17.1.2. Other CNS drugs
17.1.3. Anti-Psychotic
17.1.4. Anti-Epileptics
17.1.5. Antidepressants
17.1.6. Anesthetics
17.1.7. Analgesics
17.1.8. Anti-Parkinson drugs
17.2. Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.2.1. Hospital Pharmacies
17.2.2. Retail Pharmacies/ Drug Stores
17.2.3. Other Distribution Channel
17.3. Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.3.1. Oral
17.3.2. Intravenous
17.3.3. Intranasal
17.3.4. Others
17.4. Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.4.1. Branded Drugs
17.4.2. Generic Drugs
17.5. Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.5.1. Prescription-Based Drugs
17.5.2. Over-The-Counter Drugs
18. Global Central Nervous System Drugs Market Metrics
18.1. Central Nervous System Drugs Market Size, Percentage Of GDP, Global
18.2. Per Capita Average Central Nervous System Drugs Market Expenditure, Global
19. Asia-Pacific Central Nervous System Drugs Market
19.1. Asia-Pacific Central Nervous System Drugs Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. COVID-19 Impact
19.1.4. Background Information
19.1.5. Government Initiatives
19.1.6. Regulations
19.1.7. Regulatory Bodies
19.1.8. Major Associations
19.1.9. Taxes Levied
19.1.10. Corporate Tax Structure
19.1.11. Investments
19.1.12. Major Companies
19.2. Asia-Pacific Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.3. Asia-Pacific Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.4. Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.5. Asia-Pacific Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
19.6. Asia-Pacific Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country
19.7. Asia-Pacific Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
19.8. Asia-Pacific Central Nervous System Drugs Market Metrics
19.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Asia-Pacific Major Countries
19.9. Asia-Pacific Central Nervous System Drugs Market: Country Analysis
19.10. Australia Central Nervous System Drugs Market
19.11. Australia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.12. Australia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.13. Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.14. China Central Nervous System Drugs Market
19.15. China Central Nervous System Drugs Market Overview
19.15.1. Country Information
19.15.2. Market Information
19.15.3. COVID-19 Impact
19.15.4. Background Information
19.15.5. Government Initiatives
19.15.6. Regulations
19.15.7. Regulatory Bodies
19.15.8. Major Associations
19.15.9. Taxes Levied
19.15.10. Corporate Tax Structure
19.15.11. Investments
19.15.12. Major Companies
19.16. China Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.17. China Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.18. China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.19. Hong Kong Central Nervous System Drugs Market
19.20. Hong Kong Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.21. Hong Kong Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.22. India Central Nervous System Drugs Market
19.23. India Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.24. India Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.25. India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.26. Indonesia Central Nervous System Drugs Market
19.27. Indonesia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.28. Indonesia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.29. Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.30. Japan Central Nervous System Drugs Market
19.31. Japan Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.32. Japan Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.33. Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.34. Malaysia Central Nervous System Drugs Market
19.35. Malaysia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.36. Malaysia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.37. New Zealand Central Nervous System Drugs Market
19.38. New Zealand Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.39. New Zealand Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.40. Philippines Central Nervous System Drugs Market
19.41. Philippines Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.42. Philippines Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.43. Singapore Central Nervous System Drugs Market
19.44. Singapore Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.45. Singapore Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.46. South Korea Central Nervous System Drugs Market
19.47. South Korea Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.48. South Korea Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.49. South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.50. Thailand Central Nervous System Drugs Market
19.51. Thailand Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.52. Thailand Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.53. Vietnam Central Nervous System Drugs Market
19.54. Vietnam Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.55. Vietnam Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20. Western Europe Central Nervous System Drugs Market
20.1. Western Europe Central Nervous System Drugs Market Overview
20.1.1. Region Information
20.1.2. Market Information
20.1.3. COVID Impact
20.1.4. Background Information
20.1.5. Government Initiatives
20.1.6. Regulations
20.1.7. Regulatory Bodies
20.1.8. Major Associations
20.1.9. Taxes Levied
20.1.10. Corporate Tax Structure
20.1.11. Investments
20.1.12. Major Companies
20.2. Western Europe Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.3. Western Europe Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.4. Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20.5. Western Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
20.6. Western Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country
20.7. Western Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
20.8. Western Europe Central Nervous System Drugs Market Metrics
20.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Western Europe Major Countries
20.9. Western Europe Central Nervous System Drugs Market: Country Analysis
20.10. Austria Central Nervous System Drugs Market
20.11. Austria Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.12. Austria Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.13. Belgium Central Nervous System Drugs Market
20.14. Belgium Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.15. Belgium Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.16. Denmark Central Nervous System Drugs Market
20.17. Denmark Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.18. Denmark Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.19. Finland Central Nervous System Drugs Market
20.20. Finland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.21. Finland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.22. France Central Nervous System Drugs Market
20.23. France Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.24. France Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.25. France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20.26. Germany Central Nervous System Drugs Market
20.27. Germany Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.28. Germany Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.29. Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20.30. Ireland Central Nervous System Drugs Market
20.31. Ireland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.32. Ireland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.33. Italy Central Nervous System Drugs Market
20.34. Italy Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.35. Italy Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.36. Netherlands Central Nervous System Drugs Market
20.37. Netherlands Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.38. Netherlands Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.39. Norway Central Nervous System Drugs Market
20.40. Norway Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.41. Norway Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.42. Portugal Central Nervous System Drugs Market
20.43. Portugal Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.44. Portugal Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.45. Spain Central Nervous System Drugs Market
20.46. Spain Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.47. Spain Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.48. Sweden Central Nervous System Drugs Market
20.49. Sweden Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.50. Sweden Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.51. Switzerland Central Nervous System Drugs Market
20.52. Switzerland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.53. Switzerland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.54. UK Central Nervous System Drugs Market
20.55. UK Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.56. UK Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.57. UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
21. Eastern Europe Central Nervous System Drugs Market
21.1. Eastern Europe Central Nervous System Drugs Market Overview
21.1.1. Region Information
21.1.2. Market Information
21.1.3. COVID Impact
21.1.4. Background Information
21.1.5. Government Initiatives
21.1.6. Regulations
21.1.7. Regulatory Bodies
21.1.8. Major Associations
21.1.9. Taxes Levied
21.1.10. Corporate Tax Structure
21.1.11. Investments
21.1.12. Major Companies
21.2. Eastern Europe Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
21.3. Eastern Europe Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
21.4. Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
21.5. Eastern Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
21.6. Eastern Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country
21.7. Eastern Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
21.8. Eastern Europe Central Nervous System Drugs Market Metrics
21.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Eastern Europe Major Countries
21.9. Eastern Europe Central Nervous System Drugs Market: Country Analysis
21.10. Czech Republic Central Nervous System Drugs Market
21.11. Czech Republic Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
21.12. Czech Republic Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
21.13. Poland Central Nervous System Drugs Market
21.14. Poland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
21.15. Poland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
21.16. Romania Central Nervous System Drugs Market
21.17. Romania Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
21.18. Romania Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
21.19. Russia Central Nervous System Drugs Market
21.20. Russia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
21.21. Russia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
21.22. Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
22. North America Central Nervous System Drugs Market
22.1. North America Central Nervous System Drugs Market Overview
22.1.1. Region Information
22.1.2. Market Information
22.1.3. COVID-19 Impact
22.1.4. Background Information
22.1.5. Government Initiatives
22.1.6. Regulations
22.1.7. Regulatory Bodies
22.1.8. Investments
22.1.9. Major Associations
22.1.10. Tax Levied
22.1.11. Corporate Tax Structure
22.1.12. Major Companies
22.2. North America Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
22.3. North America Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
22.4. North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
22.5. North America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
22.6. North America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country
22.7. North America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
22.8. North America Central Nervous System Drugs Market Metrics
22.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, North America Major Countries
22.9. North America Central Nervous System Drugs Market: Country Analysis
22.10. Canada Central Nervous System Drugs Market
22.11. Canada Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
22.12. Canada Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
22.13. Mexico Central Nervous System Drugs Market
22.14. Mexico Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
22.15. Mexico Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
22.16. USA Central Nervous System Drugs Market
22.17. USA Central Nervous System Drugs Market Overview
22.17.1. Country Information
22.17.2. Market Information
22.17.3. COVID-19 Impact
22.17.4. Background Information
22.17.5. Government Initiatives
22.17.6. Regulations
22.17.7. Regulatory Bodies
22.17.8. Investments
22.17.9. Major Associations
22.17.10. Corporate Tax Structure
22.17.11. Major Companies
22.18. USA Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
22.19. USA Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
22.20. USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
23. South America Central Nervous System Drugs Market
23.1. South America Central Nervous System Drugs Market Overview
23.1.1. Region Information
23.1.2. Market Information
23.1.3. COVID-19 Impact
23.1.4. Background Information
23.1.5. Regulations
23.1.6. Regulatory Bodies
23.1.7. Investments
23.1.8. Major Associations
23.1.9. Tax Levied
23.1.10. Corporate Tax Structure
23.1.11. Major Companies
23.2. South America Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
23.3. South America Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
23.4. South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
23.5. South America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
23.6. South America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country
23.7. South America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
23.8. South America Central Nervous System Drugs Market Metrics
23.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, South America Major Countries
23.9. South America Central Nervous System Drugs Market: Country Analysis
23.10. Argentina Central Nervous System Drugs Market
23.11. Argentina Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
23.12. Argentina Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
23.13. Brazil Central Nervous System Drugs Market
23.14. Brazil Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
23.15. Brazil Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
23.16. Brazil Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
23.17. Chile Central Nervous System Drugs Market
23.18. Chile Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
23.19. Chile Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
23.20. Colombia Central Nervous System Drugs Market
23.21. Colombia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
23.22. Colombia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
23.23. Peru Central Nervous System Drugs Market
23.24. Peru Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
23.25. Peru Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
23.26. Venezuela Central Nervous System Drugs Market
23.27. Venezuela Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
23.28. Venezuela Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
24. Middle East Central Nervous System Drugs Market
24.1. Middle East Central Nervous System Drugs Market Overview
24.1.1. Region Information
24.1.2. Market Information
24.1.3. COVID-19 Impact
24.1.4. Background Information
24.1.5. Government Initiatives
24.1.6. Regulations
24.1.7. Regulatory Bodies
24.1.8. Major Associations
24.1.9. Taxes Levied
24.1.10. Corporate Tax Structure
24.1.11. Investments
24.1.12. Major Companies
24.2. Middle East Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
24.3. Middle East Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
24.4. Middle East Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
24.5. Middle East Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
24.6. Middle East Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country
24.7. Middle East Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
24.8. Middle East Central Nervous System Drugs Market Metrics
24.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Middle East Major Countries
24.9. Middle East Central Nervous System Drugs Market: Country Analysis
24.10. Israel Central Nervous System Drugs Market
24.11. Israel Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
24.12. Israel Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
24.13. Saudi Arabia Central Nervous System Drugs Market
24.14. Saudi Arabia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
24.15. Saudi Arabia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
24.16. Turkey Central Nervous System Drugs Market
24.17. Turkey Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
24.18. Turkey Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
24.19. UAE Central Nervous System Drugs Market
24.20. UAE Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
24.21. UAE Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
25. Africa Central Nervous System Drugs Market
25.1. Africa Central Nervous System Drugs Market Overview
25.1.1. Region Information
25.1.2. Market Information
25.1.3. COVID-19 Impact
25.1.4. Background Information
25.1.5. Government Initiatives
25.1.6. Regulations
25.1.7. Regulatory Bodies
25.1.8. Major Associations
25.1.9. Taxes Levied
25.1.10. Corporate Tax Structure
25.1.11. Investments
25.1.12. Major Companies
25.2. Africa Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
25.3. Africa Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
25.4. Africa Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
25.5. Africa Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
25.6. Africa Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country
25.7. Africa Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
25.8. Africa Central Nervous System Drugs Market Metrics
25.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Africa Major Countries
25.9. Africa Central Nervous System Drugs Market: Country Analysis
25.10. Egypt Central Nervous System Drugs Market
25.11. Egypt Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
25.12. Egypt Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
25.13. Nigeria Central Nervous System Drugs Market
25.14. Nigeria Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
25.15. Nigeria Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
25.16. South Africa Central Nervous System Drugs Market
25.17. South Africa Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
25.18. South Africa Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
26. Global Central Nervous System Drugs Market Competitive Landscape
26.1. Biogen Inc.
26.1.1. Company Overview
26.1.2. Products And Services
26.1.3. Business Strategy
26.1.4. Financial Overview
26.2. Johnson & Johnson
26.2.1. Company Overview
26.2.2. Products And Services
26.2.3. Business Strategy
26.2.4. Financial Overview
26.3. Hoffmann-La Roche Ltd
26.3.1. Company Overview
26.3.2. Products And Services
26.3.3. Business Strategy
26.3.4. Financial Overview
26.4. Novartis AG
26.4.1. Company Overview
26.4.2. Products And Services
26.4.3. Business Strategy
26.4.4. Financial Overview
26.5. UCB
26.5.1. Company Overview
26.5.2. Products And Services
26.5.3. Business Strategy
26.5.4. Financial Overview
27. Key Mergers And Acquisitions In The Central Nervous System Drugs Market
27.1. Ethypharm Acquired Altan Pharma
27.2. Angelini Pharma Acquired Arvelle Therapeutics
27.3. Novartis Acquired Cadent Therapeutics
27.4. Biogen Acquired Sangamo Therapeutics
27.5. Supernus Acquired US WorldMeds
27.6. Permira Acquired Neuraxpharm
27.7. UCB Acquired Handl Therapeutics
27.8. Neurocrine Biosciences Acquired Voyager Therapeutics
27.9. Eli Lilly Acquired Loxo Oncology Inc.
27.10. Neuraxpharm Acquired Farmax
27.11. CNS Pharmaceuticals Acquired Houston Pharmaceuticals Inc.
27.12. H. Lundbeck Acquired Prexton Therapeutics
27.13. Novartis Acquired AveXis
27.14. Biolab Pharma Acquired Avtavis Brazil
27.15. Mitsubishi Tanabe Pharma Acquired NeuroDerm
27.16. Eli Lilly Acquires CoLucid
27.17. Lupin Acquired Temmler Pharma
28. Market Background: Pharmaceutical Drugs Market
28.1. Pharmaceutical Drugs Market Characteristics
28.1.1. Market Definition
28.1.2. Segmentation By Type
28.2. Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 – 2025, Value ($ Billion)
28.3. Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)
28.4. Global Pharmaceutical Drugs Market, 2015 – 2025, Historic And Forecast, By Region
29. Central Nervous System Drugs Market Future Outlook and Potential Analysis
29.1. Global Central Nervous System Drugs Market In 2025 – Countries Offering Most New Opportunities
29.2. Global Central Nervous System Drugs Market In 2025 – Segments Offering Most New Opportunities
29.3. Global Central Nervous System Drugs Market In 2025 – Growth Strategies
29.3.1. Market Trend Based Strategies
29.3.2. Competitor Strategies
30. Appendix
30.1. Market Data Sources
30.2. NAICS Definitions Of Industry Covered In This Report
30.3. Research Methodology
30.4. Currencies
30.5. Research Inquiries
30.6. The Business Research Company
30.7. Copyright and Disclaimer
